DK2165704T3 - Anvendelse af alverin ved behandling af hudsygdomme - Google Patents

Anvendelse af alverin ved behandling af hudsygdomme

Info

Publication number
DK2165704T3
DK2165704T3 DK09171044.2T DK09171044T DK2165704T3 DK 2165704 T3 DK2165704 T3 DK 2165704T3 DK 09171044 T DK09171044 T DK 09171044T DK 2165704 T3 DK2165704 T3 DK 2165704T3
Authority
DK
Denmark
Prior art keywords
alverine
skin diseases
treatment
antibacterial
salts
Prior art date
Application number
DK09171044.2T
Other languages
English (en)
Inventor
Francois Fauran
Original Assignee
Francois Fauran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francois Fauran filed Critical Francois Fauran
Application granted granted Critical
Publication of DK2165704T3 publication Critical patent/DK2165704T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK09171044.2T 2008-09-23 2009-09-23 Anvendelse af alverin ved behandling af hudsygdomme DK2165704T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0856382A FR2936149B1 (fr) 2008-09-23 2008-09-23 Utilisation de l'alverine dans le traitement des affections cutanees

Publications (1)

Publication Number Publication Date
DK2165704T3 true DK2165704T3 (da) 2012-08-06

Family

ID=40513974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09171044.2T DK2165704T3 (da) 2008-09-23 2009-09-23 Anvendelse af alverin ved behandling af hudsygdomme

Country Status (7)

Country Link
EP (1) EP2165704B1 (da)
AT (1) ATE553760T1 (da)
DK (1) DK2165704T3 (da)
ES (1) ES2386558T3 (da)
FR (1) FR2936149B1 (da)
PL (1) PL2165704T3 (da)
PT (1) PT2165704E (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500738A1 (en) † 2010-10-21 2016-08-05 Galderma Sa Brimonidine gel compositions and methods of use
CN102626415B (zh) * 2012-03-21 2014-08-06 山东省千佛山医院 四环素类药物联合应用氟康唑在制备抗真菌产品中的应用及其产品
CN104704127A (zh) * 2012-07-13 2015-06-10 莱雅公司 体外诊断受试者的薄皮状态的方法及相关应用
KR102057173B1 (ko) 2018-04-05 2019-12-18 삼척시 알베린 화합물을 유효성분으로 포함하는 항산화 조성물
KR102261340B1 (ko) * 2018-12-28 2021-06-07 삼척시 민물김 추출물을 유효성분으로 포함하는 염증성 피부 질환 예방 또는 치료용 조성물
CA3185522A1 (fr) * 2020-07-24 2022-01-27 Vincent Procaccio Utilisation d'alverine ou de ses derives pour le traitement de maladies mitochondriales ou d'un dysfonctionnement associe a des deficiences en complexe mitochondrial i
FR3154314B1 (fr) * 2023-10-20 2026-05-15 Laboratoires Mayoly Spindler Composition pharmaceutique comprenant de la siméticone et de l’alvérine citrate, composition pharmaceutique contenant de la siméticone, composition pharmaceutique,comprenant de l’alvérine citrate, et leurs procédés de fabrication.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798590B1 (fr) * 1999-09-21 2001-11-30 Oreal Utilisation de l'alverine pour diminuer les rides
FR2823109B1 (fr) 2001-04-09 2003-05-23 Oreal Utilisation de l'alverine ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2823114B1 (fr) * 2001-04-09 2003-05-23 Oreal Utilisation de l'alverine ou de l'un de ses sels
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
US20060223891A1 (en) 2003-06-13 2006-10-05 Cerep Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression
FR2900337A1 (fr) 2006-04-28 2007-11-02 Cerep Sa Utilisation de l'alverine pour le traitement des dysfonctions sexuelles
WO2008009860A2 (fr) * 2006-07-21 2008-01-24 L'oreal Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau

Also Published As

Publication number Publication date
FR2936149B1 (fr) 2013-01-04
PT2165704E (pt) 2012-07-05
ATE553760T1 (de) 2012-05-15
FR2936149A1 (fr) 2010-03-26
PL2165704T3 (pl) 2012-10-31
EP2165704B1 (fr) 2012-04-18
EP2165704A1 (fr) 2010-03-24
ES2386558T3 (es) 2012-08-22

Similar Documents

Publication Publication Date Title
NO20084502L (no) Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
MY160004A (en) Heterocyclically substituted aryl compounds as hif inhibitors
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
TW200833330A (en) Substituted dihydropyrazolones and their use
FR2936149B1 (fr) Utilisation de l'alverine dans le traitement des affections cutanees
CL2011002648A1 (es) Composicion topica que comprende un compuesto derivado de 1,2,4-tiadiazol o tiourea, un agente modificador de la viscosidad, un conservante y agua; estuche para la composicion; metodo para preparar la composicion; y uso para tratar una enfermedad o trastorno dermatologico mediado por un receptor de melanocortina tal como acne.
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
PH12021551010A1 (en) Compositions for treating biofilms without inducing antimicrobial resistance
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
UA114528C2 (uk) Комбінації активних сполук, що містять карбоксамідні похідні та засіб біологічної боротьби
BRPI0819028A2 (pt) "composição de cuidados com os cabelos/couro cabeludo, método de tratar couro cabeludo ou cabelos e método de depositar um agente antisseborreia sobre o couro cabeludo ou pele"
EA200970932A1 (ru) Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа
UA114304C2 (uk) Спосіб зниження сироваткових рівнів сечової кислоти у людини
ATE543492T1 (de) Behandlung von lungenkrebs
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
BRPI0720236A2 (pt) Composto ou sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar uma infecção bacteriana em um animal de sangue quente tal como o ser humano, e, composição farmacêutica
WO2011056871A3 (en) Rhamnolipid mechanism
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
WO2007120665A3 (en) Formulation and method for a skin treatment for animals
WO2006053788A3 (en) Alterations in seborrheic keratoses and their applications
ATE503455T1 (de) Haarbehandlugsverfahren
WO2010014943A3 (en) Methionine analogs and methods of using same